• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    New Dell Healthcare CMO Comments on Company's Genomics Focus

    Morag Mcgreevey
    Jul. 21, 2015 09:26AM PST
    Genetics Investing

    Dell Healthcare and Life Sciences (NASDAQ:DELL) announced a new CMO on Monday. Dr. Nick van Terheyden will take over the position, a month after stepping down as CMIO at Nuance Communications.

    Dell Healthcare and Life Sciences (NASDAQ:DELL) announced a new CMO on Monday. Dr. Nick van Terheyden will take over the position, a month after stepping down as CMIO at Nuance Communications.
    According to an article published on MedCityNews:

    Plano, Texas-based Dell Healthcare & Life Sciences has groups focused on mobile health, cloud computing, cybersecurity and genomics, among other areas. Dell’s healthcare cloud currently stores about 9 billion medical images, van Terheyden said, and most are tied to analytics systems.
    In the area of genomics, Dell is partnering with the Translational Genomics Research Institute (TGen) on what the company says is the first FDA-approved personalized medicine trial for pediatric cancer.

    Van Terheyden, a supporter of genomics research, states:

    I’m very much in the Eric Topol camp of where things are going.

    Click here to read the full article on MedCityNews.
     

    personalized medicinegenomics research
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×